About Emilia Díaz

Bioentrepreneur, writer and speaker. Founder of Kaitek Labs, one of the first synbio companies in her native Chile. Singularity University alumn. Currently blogs for Synbiobeta and Nature Biotechnology.

Drew Endy to Keynote SynBioBeta London

One of the first names you come across when you dive into the world of synthetic biology is Drew Endy. His early foundational work in synthetic biology is clear: this Stanford Professor not only developed the world’s first “fabless” engineering [...]

By | March 13th, 2017|News|

Kite Pharma’s Engineered T-Cell Therapies for Cancers Delivers Astonishing Results

Kite Pharma’s gene therapy trial has just delivered astonishing results: 41% of patients in response and 36% in complete response at month 6 after a single round of treatment. The news shook the bio and med industry last week, skyrocketing [...]

By | March 7th, 2017|BioPharma & Healthcare, News, Therapeutics|

46 Organizations Making Biology Easier to Engineer

Synthetic biology has been a joint effort since its conception. From academic researchers to legislators and venture capitalists, synbio as both a technology and innovation ecosystem has been forged by different hands and different perspectives. These are some of the [...]

An Interview with Daniela Quaglia on Synbio and Science Communication

“I like to define myself as a versatile person.” This is how Daniela Quaglia, scientist, synthetic biology enthusiast, writer, editor and occasional actress, introduces herself. Daniela is a prominent scientific communicator with a close history to the SynBioBeta community, which [...]

By | February 15th, 2017|Education, Industry Support, News|

Riffyn and Novozymes Join Forces to Accelerate the Digital Future of Scientific Research

During the SynBioBeta SF conference last October, Riffyn announced the launch of its cloud-based research process design software. The company’s mission to change the pace of research and development through software innovation has now reached new speeds through a key [...]

IndieBio Reveals Its Fourth Class of SynBio Startups – Part 2

Did the first part of IndieBio’s latest batch leave you wanting to know more? Here are the remaining seven teams that form the accelerator’s Class of 2016-2017. Remember to check out their Demo Day on February 9th! Mendel Health (USA) [...]

By | February 1st, 2017|News|